Ventripoint Diagnostics Ltd (VPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 60 | 28 | 13 | 11 | 14 |
| Accounts receivable | 13 | 20 | 29 | -65 | 29 |
| Accounts payable and accrued liabilities | 336 | 144 | -370 | -3 | -1 |
| Other Working Capital | 478 | 104 | -253 | -249 | 121 |
| Other Operating Activity | -3,268 | -3,345 | -2,489 | -1,893 | -1,771 |
| Operating Cash Flow | $-2,381 | $-3,049 | $-3,070 | $-2,199 | $-1,609 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | -27 | -39 | -6 | 0 |
| Purchase Sale Intangibles | N/A | N/A | 0 | -7 | N/A |
| Investing Cash Flow | $-17 | $-27 | $-39 | $-13 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 220 | N/A | N/A | N/A | N/A |
| Debt Issued | 1,511 | N/A | N/A | 0 | 234 |
| Debt Repayment | -46 | 0 | -109 | -160 | -312 |
| Common Stock Issued | 703 | 1,865 | 4,678 | 637 | 3,903 |
| Other Financing Activity | -44 | -28 | -322 | -41 | -462 |
| Financing Cash Flow | $2,344 | $1,836 | $4,246 | $436 | $3,362 |
| Exchange Rate Effect | 2 | -52 | 31 | -7 | 17 |
| Beginning Cash Position | 67 | 1,359 | 191 | 1,975 | 206 |
| End Cash Position | 14 | 67 | 1,359 | 191 | 1,977 |
| Net Cash Flow | $-54 | $-1,240 | $1,137 | $-1,777 | $1,754 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,381 | -3,049 | -3,070 | -2,199 | -1,609 |
| Capital Expenditure | -17 | -27 | -39 | -14 | N/A |
| Free Cash Flow | -2,398 | -3,076 | -3,109 | -2,213 | -1,609 |